Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Ignite Investment Summit Hong Kong Presentation

by admin March 27, 2025
March 27, 2025
Ignite Investment Summit Hong Kong Presentation

Battery Age Minerals Ltd (ASX: BM8; “Battery Age” or “the Company”) is pleased to advise of its participation at the Ignite Investment Summit being held this week in Hong Kong.

BM8’s Chief Executive Officer, Mr Nigel Broomham, will be presenting the Company’s strategy for progressing its diversified & strategic portfolio of projects in Austria, Argentina and Canada today at 11.00am AWST. Attached is the presentation that Mr Broomham will be speaking to at the conference.

Investors can register to attend the conference at: weareignite.com/contact/#investor

Battery Age CEO Nigel Broomham commented:

‘Fresh from recent field visits to Austria and Argentina, and following positive advancements across our Bleiberg, El Aguila, and Falcon Lake projects, we look forward to presenting a number of updates and meaningful insights to a fantastic group of investors and stakeholders.”

Click here for the full ASX Release

This post appeared first on investingnews.com

previous post
Nvidia’s CEO did a Q&A with analysts. What he said and what Wall Street thinks about it.
next post
Keith Weiner: All Roads Lead to Gold Right Now, Price to Go Much Higher

Related Posts

Platinum Price Breaks Out as Chinese Demand and...

May 29, 2025

Editor’s Picks: Gold Faces Bumpy Week on Trade...

June 1, 2025

Crypto Market Recap: TradFi Deepens Crypto Collaboration, BlackRock...

March 16, 2025

Jordan Roy-Byrne: Gold Stocks in “Sweet Spot,” Setting...

March 26, 2025

Gold vs. Platinum: Which is the True Metal...

February 14, 2025

Finlay Minerals Ltd. engages Investing News Network

July 8, 2025

Byron King: Fear Trade in Play — Make...

April 3, 2025

SAGA Metals Updates On Rio Tinto’s Field Progress...

February 26, 2025

BHP to Invest Up to AU$40 Million in...

March 14, 2025

Cardiex Completes Placement & Launches Entitlement Offer

May 30, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 4

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 5

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 6

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 wallstreetwizardry.com | All Rights Reserved